Atrial Fibrillation Clinical Trial
— MOTIVATE AFOfficial title:
Motivational Support for Patients With Atrial Fibrillation to Promote Weight Loss
Verified date | August 2019 |
Source | The Leeds Teaching Hospitals NHS Trust |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study is designed to look at the impact that support and motivation has on patients with
Atrial Fibrillation's ability to lose weight and maintain this. We believe that weight loss
has a positive impact on the reduction of symptoms of atrial fibrillation and can decrease
the likelihood of the arrhythmia returning following cardio version.
This study is designed for patients who have a diagnosis of Atrial Fibrillation and have a
Body Mass Index greater than 27.
In the study, we plan to provide support and motivation to patients with atrial fibrillation
to encourage weight loss. There are several weight loss strategies available to follow.
Information will be provided about each strategy to encourage informed choices. If the
initial strategy chosen is not working, this can be change to a more suitable one as
required. Follow up will be by telephone at 2 and 4 weeks then every month thereafter where
you will be asked your weight and to clarify the weight loss strategy you are following. You
will be seen at 6 and 12 months where you will have an ECG, BP check and your weight
measured. A final telephone assessment will take place at 24 months.
We hope that the research will in the future help patients with Atrial Fibrillation manage
and maintain their weight loss to improve their symptoms and prevent recurrence of the
arrhythmia. The results of this study could potentially change practice in our centre by
providing more structured weight loss clinics for patients with Atrial Fibrillation
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | September 1, 2021 |
Est. primary completion date | September 1, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 99 Years |
Eligibility |
Inclusion Criteria: - Age =18 years - BMI>27 - Symptomatic AF - Committed to monthly follow up phone calls and bi annual visits. Exclusion Criteria: - Any co morbidity that would reduce life expectancy to within the year. - Unable to commit to follow up. - Patients recruited to weight loss studies that are on going |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
The Leeds Teaching Hospitals NHS Trust |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight loss of at least 3% at end of year 1 | Participant has lost weight at end of year 1. (The weight loss is graded <3%, 3-10%, .10%) | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Completed |
NCT04571385 -
A Study Evaluating the Efficacy and Safety of AP30663 for Cardioversion in Participants With Atrial Fibrillation (AF)
|
Phase 2 | |
Terminated |
NCT04115735 -
His Bundle Recording From Subclavian Vein
|
||
Completed |
NCT05366803 -
Women's Health Initiative Silent Atrial Fibrillation Recording Study
|
N/A | |
Completed |
NCT02864758 -
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
|
||
Recruiting |
NCT05442203 -
Electrocardiogram-based Artificial Intelligence-assisted Detection of Heart Disease
|
N/A | |
Completed |
NCT05599308 -
Evaluation of Blood Pressure Monitor With AFib Screening Feature
|
N/A | |
Completed |
NCT03790917 -
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrY
|
||
Enrolling by invitation |
NCT05890274 -
Atrial Fibrillation (AF) and Electrocardiogram (EKG) Interpretation Project ECHO
|
N/A | |
Recruiting |
NCT05266144 -
Atrial Fibrillation Patients Treated With Catheter Ablation
|
||
Recruiting |
NCT05316870 -
Construction and Effect Evaluation of Anticoagulation Management Model in Atrial Fibrillation
|
N/A | |
Not yet recruiting |
NCT06023784 -
The Impact of LBBAP vs RVP on the Incidence of New-onset Atrial Fibrillation in Patients With Atrioventricular Block
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Recruiting |
NCT04092985 -
Smart Watch iECG for the Detection of Cardiac Arrhythmias
|
||
Completed |
NCT04087122 -
Evaluate the Efficiency Impact of Conducting Active Temperature Management During Cardiac Cryoablation Procedures
|
N/A | |
Completed |
NCT06283654 -
Relieving the Emergency Department by Using a 1-lead ECG Device for Atrial Fibrillation Patients After Pulmonary Vein Isolation
|
||
Recruiting |
NCT05416086 -
iCLAS™ Cryoablation System Post-Market Clinical Follow-up (PMCF) Study
|
N/A | |
Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|
||
Completed |
NCT04546763 -
Study Watch AF Detection At Home
|
||
Completed |
NCT03761394 -
Pulsewatch: Smartwatch Monitoring for Atrial Fibrillation After Stroke
|
N/A |